#478 — The Psychedelic Mind

第478期 — 致幻心灵

Making Sense with Sam Harris

2026-05-30

30 分钟

单集简介 ...

Sam Harris speaks with Robin Carhart-Harris about psychedelic research and its therapeutic potential. They discuss the current state of the field, the FDA denial of MDMA-assisted therapy for PTSD, the critical role of set and setting, risks for vulnerable populations, the REBUS model of how psychedelics work on the brain, the default mode network and ego dissolution, microdosing, the neuroscience of consciousness, DMT entities, and other topics. If the Making Sense podcast logo in your player is BLACK, you can SUBSCRIBE to gain access to all full-length episodes at samharris.org/subscribe.
更多

单集文稿 ...

  • You're listening to Making Sense with Sam Harris.

  • This is the free version of the podcast, so you'll only hear the first part of today's conversation.

  • If you want the full episode and every episode, you can subscribe at SamHarris.org.

  • There are no ads on this show.

  • It runs entirely on subscriber support.

  • If you enjoy what we're doing here and find it valuable, please consider subscribing today.

  • I am here with Robin Carhart-Harris.

  • Robin, thanks for joining me again.

  • Thanks for having me on.

  • So remind people where you are doing your research on psychedelics.

  • I'm at the University of California, San Francisco.

  • I have my lab there.

  • And what's the focus of your research at this point?

  • It's consciousness science and how it's encoded in brain activity.

  • That's a big part of it.

  • How can we use psychedelics to try and tackle that question?

  • And it translates into therapeutic applications of psychedelics as well.

  • Also, look at harms.

  • Yeah, so try and cover the much of the full gamut of psychedelic science and research.

  • Yeah.